Review of Lung Cancer Patient Characteristics and Treatment Strategies in the Pandemic Covid-19 Year
Author:
Crvenkova Simonida1, Jakimovki Dragan1, Ristovski Vladimir1
Affiliation:
1. 1 University Clinic of Radiotherapy and Oncology , Faculty of Medicine , Skopje , RN Macedonia
Abstract
Abstract
Introduction: It is estimated that delays in diagnosis due to the COVID-19 pandemic in North Macedonia could result in significant reductions in the number of potentially curative stages in lung cancer patients.
Purpose: The aim of this study was to review patient characteristics and treatment strategies of lung cancer patients treated at the University Clinic of Radiotherapy and Oncology (UCRO), during the pre-pandemic year (from 1 of March 2019 to the end of February 2020) and the pandemic year (from 1 of March 2020 to the end of February 2021).
Material: We analyzed eligible patients in the course of these two years according to patient characteristics and treatment strategies.
Results: We have a record increasing in number of undefined lung cancer patients without any pathological or histological conformation (11% pandemic year compared to 7% in the previous year), and an increased number of stage III and IV NSCLC patients in the pandemic year 449 (87%), in comparison to the pre-pandemic year of 403 (74%) patients. We have found a decreasing number of stage II NSCLC patients in the pandemic year 82 (13%) compared to 141 (26%) patients in the pre-pandemic year. We also note a decreasing number of patients with NSCLC operated on from 218 to 123 in the pandemic group. Due to frequent check-ups for COVID-19, we report an increasing number of early stage IA and stage IB patients, treated only by surgery.
Conclusions: The strict screening and admittance criteria put in place by hospitals during the pandemic might have improved the oncology treatment course of lung cancer patients.
Publisher
Walter de Gruyter GmbH
Reference22 articles.
1. Haxhihamza K, Arsova S, Bajraktarov S, Kalpak G, Stefanovski B, Novotni A, Milutinovic M. Patient Satisfaction with Use of Telemedicine in University Clinic of Psychiatry: Skopje, North Macedonia During COVID-19 Pandemic. Telemed, J E Health. 27(4):464-467, 2021 2. Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K. et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol 2020;21, 335–337 3. Zheng, Z., Peng, F., Xu, B., Zhao, J., Liu, H., Peng, J. et al. Risk factors of critical & mortal COVID-19 cases: a systematic literature review and meta-analysis. J. Infect. 81, e16–e25, 2020 4. Richards, M., Anderson, M., Carter, P., Ebert, B. L. & Mossialos, E. The impact of the COVID-19 pandemic on cancer care. Nat. Cancer. 1:565–567, 2020 5. Maringe, C., Spicer, J., Morris, M., Purushotham, A., Nolte, E., Sullivan, R. et al. The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis: a national population based modelling study. Lancet Oncol. 21:1023–1034, 2020.
|
|